Position in DXCM
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$538
+$36 QoQ
Shares Held
8
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#945
of 966 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Triumph Capital Management holds $513,627 across 12 Medical Devices names. DXCM ranks #10 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
3,750 | $293,362 | |
| 2 | ABT |
Abbott Laboratories
|
840 | $76,221 | |
| 3 | SYK |
Stryker Corp
|
208 | $65,486 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
1,005 | $64,330 | |
| 5 | TMDX |
TransMedics Group, Inc.
|
100 | $6,642 | |
| 6 | BSX |
Boston Scientific Corp
|
60 | $2,560 | |
| 7 | STE |
STERIS plc
|
9 | $1,895 | |
| 8 | EW |
Edwards Lifesciences Corp
|
13 | $1,175 |
All Filings in DXCM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538 | 8 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $502 | 8 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $132 | 2 | Shares | Sole | 2026-02-12 | |
| 2023-12-31 | $1,117,306 | 9,004 | Shares | Sole | 2024-02-05 | |
| No filing history on record for this holder in this stock. | ||||||